Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.6800 (-4.54%) ($5.6800 - $5.6800) on Mon. Mar. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.06% (three month average) | RSI | 41 | Latest Price | $5.6800(-4.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -3.7% a day on average for past five trading days. | Weekly Trend | AUTL declines -4.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) BNDX(11%) SKYY(9%) TLT(9%) BND(8%) LIT(8%) | Factors Impacting AUTL price | AUTL will decline at least -2.03% in a week (0% probabilities). TBT(-9%) USO(-7%) UNG(-7%) XLF(-4%) XLB(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.03% (StdDev 4.06%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.94(-186.97%) | Resistance Level | $6.41 | 5 Day Moving Average | $5.98(-5.02%) | 10 Day Moving Average | $6.38(-10.97%) | 20 Day Moving Average | $6.41(-11.39%) | To recent high | -39.5% | To recent low | 0% | Market Cap | $297m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |